Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis
TAK-IMPACT
1 other identifier
observational
50
1 country
1
Brief Summary
This study aims to understand the experiences of patients with Takayasu arteritis (TAK) and how physicians manage the condition. To achieve this, two separate questionnaires will be conducted: one for patients and one for physicians.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 15, 2027
January 20, 2026
January 1, 2026
1.5 years
November 14, 2025
January 9, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Patient Perspective
To understand the lived experiences of individuals with TAK, including their symptoms, health status post-diagnosis, treatment priorities, and concerns. The questionnaire covers the following topics: * Basic background information * Living with Takayasu arteritis * Changes to health since diagnosis * Physical activity and exercise habits- measured by the International Physical Activity Questionnaire (IPAQ) * Smoking history * Mental well-being- measured by the EQ-5D instrument * Nutrition and diet * Personal views and priorities on management
Day 1
Physician Perspective
To evaluate current clinical management strategies for TAK, identify treatment priorities, and highlight areas of unmet need in clinical practice. The physician questionnaire covers the following topics: * Clinical background and experience with TAK patients * Diagnostic and treatment strategies for TAK * Consideration of cardiovascular disease risk in TAK management * Physician priorities and unmet needs of management
Day 1
Study Arms (2)
Patients with Takayasu Arteritis
Physicians Involved in the Management of Patients with Takayasu Arteritis
Interventions
An online annoymous questionnaire consisting of short-answer and multiple-choice questions
Eligibility Criteria
Participants are UK-based
You may qualify if:
- For the patient questionnaire:
- Age ≥ 18 years
- A formal diagnosis of TAK
- For the physician questionnaire
- A physician involved in the management/decision-making for patients diagnosed with TAK
You may not qualify if:
- For the patient questionnaire:
- Age \< 18 years
- Lack of a formal diagnosis of TAK
- Patients without mental capacity or willingness to provide informed consent
- Not UK based
- For the physician questionnaire
- Not involved in the management/ decision making for patients diagnosed with TAK
- Not willing to take part
- Not UK based
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Edinburgh
Edinburgh, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2025
First Posted
January 20, 2026
Study Start
October 1, 2025
Primary Completion (Estimated)
March 15, 2027
Study Completion (Estimated)
March 15, 2027
Last Updated
January 20, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share